Latest News
BioArctic and Eisai secure Priority Review in China for subcutaneous Leqembi
...
Median Technologies secures FDA clearance for AI lung cancer screening software
9 February 2026 - Software as a Medical Device (SaMD) developer Median Technologies (Euronext Growth Paris:ALMDT) announced on Monday that it has received FDA 510(k) clearance for eyonis LCS, an AI-powered software medical device for lung cancer scre...
Sanofi's rilzabrutinib receives FDA breakthrough and Japan orphan designations for rare anaemia
9 February 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Monday that the US Food and Drug Administration (FDA) has granted breakthrough therapy designation to Wayrilz (rilzabrutinib) for the treatment of ...
Insilico Medicine names new vice president, Clinical Development – Oncology
9 February 2026 - Clinical-stage biotechnology company Insilico Medicine (HK:3696) announced on Friday the appointment of Halle Zhang, PhD (Med) as vice president, Clinical Development – Oncology.Dr. Zhang will report to Feng Ren, the company&#...
Kelun-Biotech reports fourth indication for sac-TMT approved by NMPA in HR+/HER2- breast cancer
9 February 2026 - Chinese pharmaceutical company Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (HK:6990) announced on Friday that China's National Medical Products Administration (NMPA) has approved a new indication application for its TROP2-di...